DIEGO HERNANDEZ1,*, CHIH-YUAN CHENG1,2, KARLA HERNANDEZ-VILLAFUERTE1, MICHAEL SCHLANDER1,2
Oncology Research, Vol.30, No.4, pp. 173-185, 2022, DOI:10.32604/or.2022.027262
Abstract Lung cancer is the most common cancer type worldwide and has the highest and second highest mortality rate
for men and women respectively in Germany. Yet, the role of comorbid illnesses in lung cancer patient prognosis is still
debated. We analyzed administrative claims data from one of the largest statutory health insurance (SHI) funds in
Germany, covering close to 9 million people (11% of the national population); observation period was from 2005 to
2019. Lung cancer patients and their concomitant diseases were identified by ICD-10-GM codes. Comorbidities were
classified according to the Charlson Comorbidity Index (CCI). Incidence, comorbidity prevalence and… More >
Login
Register
